Mechanistic insights into Circ-MBOAT2-mediated regulation of TLK1 through miR-664b-3p in non-small cell lung cancer

DanTing Zhao1, Cong Wang1, GuangCheng Zhang1

  • 1Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Shandong First Medical University, No. 366 Taishan Street, Taishan District, Tai'an City, Shandong Province, 271000, China.

Hereditas
|May 14, 2025
PubMed
Abstract

Insights

Circular RNA MBOAT2 (circ-MBOAT2) promotes non-small cell lung cancer (NSCLC) progression by interacting with miR-664b-3p to increase TLK1 expression. Reducing circ-MBOAT2 inhibits NSCLC cell growth and immune escape.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Circular RNAs (circRNAs) are increasingly implicated in non-small cell lung cancer (NSCLC) pathogenesis.
  • The specific role of circ-MBOAT2 in NSCLC remains largely unknown.
  • Understanding circRNA mechanisms is crucial for developing novel NSCLC therapies.

Purpose of the Study:

  • To elucidate the pathogenic role of circ-MBOAT2 in NSCLC.
  • To investigate the molecular interactions involving circ-MBOAT2, miR-664b-3p, and TLK1 in NSCLC.
  • To assess the therapeutic potential of targeting the circ-MBOAT2 pathway.

Main Methods:

  • Analysis of circ-MBOAT2, miR-664b-3p, and TLK1 expression in NSCLC tissues.
  • In vitro studies using NSCLC cell lines (A549) involving gene transfection and functional assays (CCK-8, EdU, AnnexinV-PI, Transwell).
  • In vivo xenograft tumor assays and co-culture experiments with peripheral blood mononuclear cells (PBMCs) to assess immune modulation.

Main Results:

  • Circ-MBOAT2 was upregulated in NSCLC and its reduction inhibited proliferation, epithelial-mesenchymal transition (EMT), immune escape, and tumor growth.
  • A negative correlation was observed between circ-MBOAT2 and miR-664b-3p, with miR-664b-3p competing for binding.
  • TLK1 was upregulated, negatively correlated with miR-664b-3p, and positively correlated with circ-MBOAT2; TLK1 silencing suppressed NSCLC progression.

Conclusions:

  • Circ-MBOAT2 promotes NSCLC progression by sponging miR-664b-3p, leading to increased TLK1 expression.
  • This circRNA-miRNA-mRNA axis drives NSCLC cell proliferation, EMT, and immune evasion.
  • Targeting circ-MBOAT2 or the downstream pathway may offer a therapeutic strategy for NSCLC.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
2.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.3K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K